195 related articles for article (PubMed ID: 34570880)
1. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
Adams RC; Carter-Cusack D; Shaikh SN; Llanes GT; Johnston RL; Quaife-Ryan G; Boyle G; Koufariotis LT; Möller A; Blazar BR; Vukovic J; MacDonald KPA
Blood; 2022 Mar; 139(9):1389-1408. PubMed ID: 34570880
[TBL] [Abstract][Full Text] [Related]
2. CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.
Adams RC; Carter-Cusack D; Llanes GT; Hunter CR; Vinnakota JM; Ruitenberg MJ; Vukovic J; Bertolino P; Chand KK; Wixey JA; Nayler SP; Hill GR; Furlan SN; Zeiser R; MacDonald KPA
Blood; 2024 Mar; 143(10):912-929. PubMed ID: 38048572
[TBL] [Abstract][Full Text] [Related]
3. Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD.
Leveque-El Mouttie L; Koyama M; Le Texier L; Markey KA; Cheong M; Kuns RD; Lineburg KE; Teal BE; Alexander KA; Clouston AD; Blazar BR; Hill GR; MacDonald KP
Blood; 2016 Aug; 128(6):794-804. PubMed ID: 27338097
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia.
Mathew NR; Vinnakota JM; Apostolova P; Erny D; Hamarsheh S; Andrieux G; Kim JS; Hanke K; Goldmann T; Chappell-Maor L; El-Khawanky N; Ihorst G; Schmidt D; Duyster J; Finke J; Blank T; Boerries M; Blazar BR; Jung S; Prinz M; Zeiser R
J Clin Invest; 2020 Mar; 130(3):1315-1329. PubMed ID: 31846439
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.
Schultz KR; Bader S; Paquet J; Li W
Blood; 1995 Dec; 86(11):4344-52. PubMed ID: 7492796
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
[TBL] [Abstract][Full Text] [Related]
8. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
Drobyski WR; Majewski D
Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
[TBL] [Abstract][Full Text] [Related]
9. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.
Matte-Martone C; Liu J; Jain D; McNiff J; Shlomchik WD
Blood; 2008 Apr; 111(7):3884-92. PubMed ID: 18223170
[TBL] [Abstract][Full Text] [Related]
10. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease.
Duffner UA; Maeda Y; Cooke KR; Reddy P; Ordemann R; Liu C; Ferrara JL; Teshima T
J Immunol; 2004 Jun; 172(12):7393-8. PubMed ID: 15187116
[TBL] [Abstract][Full Text] [Related]
11. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
[TBL] [Abstract][Full Text] [Related]
12. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.
Zhao D; Young JS; Chen YH; Shen E; Yi T; Todorov I; Chu PG; Forman SJ; Zeng D
J Immunol; 2011 Jan; 186(2):856-68. PubMed ID: 21149609
[TBL] [Abstract][Full Text] [Related]
13. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
Müller AMS; Min D; Wernig G; Levy RB; Perez VL; Herretes S; Florek M; Burnett C; Weinberg K; Shizuru JA
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2338-2349. PubMed ID: 31415899
[TBL] [Abstract][Full Text] [Related]
14. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.
Waller EK; Ship AM; Mittelstaedt S; Murray TW; Carter R; Kakhniashvili I; Lonial S; Holden JT; Boyer MW
Blood; 1999 Nov; 94(9):3222-33. PubMed ID: 10556211
[TBL] [Abstract][Full Text] [Related]
15. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
[TBL] [Abstract][Full Text] [Related]
16. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
17. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
18. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease.
Sakoda Y; Hashimoto D; Asakura S; Takeuchi K; Harada M; Tanimoto M; Teshima T
Blood; 2007 Feb; 109(4):1756-64. PubMed ID: 17032915
[TBL] [Abstract][Full Text] [Related]
19. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
20. Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Barrett TA; Bluestone JA; Vallera DA
Blood; 1996 Jan; 87(2):827-37. PubMed ID: 8555509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]